Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

A neurosteroid can reduce caffeine-induced anxiety in rats.

Canine hair follicle cells metabolize DHEA and testosterone differently than human cells.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

The treatment slightly increased hair growth and was safe for most women.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

A rigid compound with a common structural motif was successfully synthesized.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Progesterone helps protect against stress-related memory and behavior issues in rats.

Paroxetine relieves pain by increasing allopregnanolone levels.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

Synthetic hormone treatment reduces melanin and hair growth in rats.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.